Literature DB >> 28416519

Time in the Therapeutic Range for Patients Taking Warfarin in Clinical Trials: Useful, but Also Misleading, Misused, and Overinterpreted.

James A Reiffel1.   

Abstract

Entities:  

Keywords:  anticoagulants; clinical trial

Mesh：

Substances：

Year:  2017        PMID： 28416519     DOI： 10.1161/CIRCULATIONAHA.116.026854

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  10 in total

1.  Impact of time in therapeutic range after left ventricular assist device placement: a comparison between thrombus and thrombus-free periods.

Authors:  Julia C Lea; Catherine K Floroff; Amanda I Ingemi; Gary R Zeevi
Journal:  J Thromb Thrombolysis       Date:  2019-04       Impact factor: 2.300

2.  The efficacy and safety of direct oral anticoagulants in noncirrhotic portal vein thrombosis.

Authors:  Leonard Naymagon; Douglas Tremblay; Nicole Zubizarreta; Erin Moshier; Kevin Troy; Thomas Schiano; John Mascarenhas
Journal:  Blood Adv       Date:  2020-02-25

Review 3.  Expert Opinion on the Use of Novel Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation for the Primary Care Setting in India: A Literature Review.

Authors:  Jamshed Dalal; Fali Poncha; Sandeep Bansal; Arvind Das; Praveen Gupta; Debasis Ghosh; Anshu Rohatgi; Murugesh S Hiremath; Kartikeya Bhargava; Arun Gopi; Mithun Mali
Journal:  Cureus       Date:  2022-05-18

4.  Left Atrial Thrombus in Atrial Fibrillation/Flutter Patients in Relation to Anticoagulation Strategy: LATTEE Registry.

Authors:  Agnieszka Kapłon-Cieślicka; Monika Gawałko; Monika Budnik; Beata Uziębło-Życzkowska; Paweł Krzesiński; Katarzyna Starzyk; Iwona Gorczyca-Głowacka; Ludmiła Daniłowicz-Szymanowicz; Damian Kaufmann; Maciej Wójcik; Robert Błaszczyk; Jarosław Hiczkiewicz; Katarzyna Łojewska; Katarzyna Mizia-Stec; Maciej T Wybraniec; Katarzyna Kosmalska; Marcin Fijałkowski; Anna Szymańska; Mirosław Dłużniewski; Maciej Haberka; Michał Kucio; Błażej Michalski; Karolina Kupczyńska; Anna Tomaszuk-Kazberuk; Katarzyna Wilk-Śledziewska; Renata Wachnicka-Truty; Marek Koziński; Paweł Burchardt; Piotr Scisło; Radosław Piątkowski; Janusz Kochanowski; Grzegorz Opolski; Marcin Grabowski
Journal:  J Clin Med       Date:  2022-05-11       Impact factor: 4.964

5.  Characteristics of patients with thromboembolic disorders on warfarin therapy in resource limited settings.

Authors:  Zipporah Kamuren; Gabriel Kigen; Alfred Keter; Alice Maritim
Journal:  BMC Health Serv Res       Date:  2018-09-19       Impact factor: 2.655

6.  TTR: Time in Therapeutic Range or "The Troublesome Report"?

Authors:  James A Reiffel
Journal:  J Innov Card Rhythm Manag       Date:  2019-01-15

7.  Standardized warfarin monitoring decreases adverse drug reactions.

Authors:  Lisa B E Shields; Paula Fowler; Diane M Siemens; Douglas J Lorenz; Kenneth C Wilson; Steven T Hester; Joshua T Honaker
Journal:  BMC Fam Pract       Date:  2019-11-07       Impact factor: 2.497

8.  Global access to affordable direct oral anticoagulants.

Authors:  Ignacio Neumann; Holger J Schünemann; Lisa Bero; Graham Cooke; Nicola Magrini; Lorenzo Moja
Journal:  Bull World Health Organ       Date:  2021-06-01       Impact factor: 9.408

9.  Association between transportation barriers and anticoagulation control among an inner-city, low-income population: A prospective observational cohort study.

Authors:  Connie H Yan; Maryam Naveed; Ali Alobaidi; Miranda Kopfman; Edith A Nutescu; Lisa K Sharp
Journal:  Res Pract Thromb Haemost       Date:  2021-10-31

Review 10.  Cognitive Function and Atrial Fibrillation: From the Strength of Relationship to the Dark Side of Prevention. Is There a Contribution from Sinus Rhythm Restoration and Maintenance?

Authors:  Emanuele Gallinoro; Saverio D'Elia; Dario Prozzo; Michele Lioncino; Francesco Natale; Paolo Golino; Giovanni Cimmino
Journal:  Medicina (Kaunas)       Date:  2019-09-13       Impact factor: 2.430
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.